New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions (Q38040666)

27 August 2017

title

New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions (English)

1 reference

27 August 2017

Graham Smith

1

1 reference

27 August 2017

Laurence Carroll

series ordinal

2

1 reference

27 August 2017

Eric O Aboagye

series ordinal

3

1 reference

27 August 2017

language of work or name

1 reference

1 December 2012

1 reference

Molecular Imaging and Biology

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

653-666

1 reference

The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Imaging and cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Development of radiotracers for oncology--the interface with pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Positron emission tomography molecular imaging for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Important parameters to consider for the characterization of PET and SPECT imaging probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Role of integrins in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Radiosynthesis and biodistribution of cyclic RGD peptides conjugated with novel [18F]fluorinated aldehyde-containing prosthetic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Apoptosis-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Site-specific labeling of annexin V with F-18 for apoptosis imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Evaluation of Chemotherapy Response in VX2 Rabbit Lung Cancer with18F-Labeled C2A Domain of Synaptotagmin I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Small-molecule biomarkers for clinical PET imaging of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

From the Gla domain to a novel small-molecule detector of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

18F-ML-10, a PET Tracer for Apoptosis: First Human Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Imaging apoptosis with positron emission tomography: 'bench to bedside' development of the caspase-3/7 specific radiotracer [(18)F]ICMT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphonium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Imaging hypoxia in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Stroma targeting nuclear imaging and radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

21 January 2018

Tumor Hypoxia Imaging

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

PET imaging of hypoxia using [18F]HX4: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

In vitro and in vivo evaluations of a hydrophilic 64Cu-bis(thiosemicarbazonato)-glucose conjugate for hypoxia imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Trends in nucleoside tracers for PET imaging of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Imaging of cell proliferation: status and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

[18F]FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

[(18)F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Imaging pharmacodynamics of the alpha-folate receptor-targeted thymidylate synthase inhibitor BGC 945.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

N(3)-Substituted thymidine analogues V: synthesis and preliminary PET imaging of N(3)-[(18)F]fluoroethyl thymidine and N(3)-[(18)F]fluoropropyl thymidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

"Click labeling" with 2-[18f]fluoroethylazide for positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Aryl Triflates and [11C]/(13C)Carbon Monoxide in the Synthesis of 11C-/13C-Amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Synthesis of [11C]/(13C)amines via carbonylation followed by reductive amination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Copper-free click chemistry for dynamic in vivo imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Strain-promoted copper-free "click" chemistry for 18F radiolabeling of bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Copper-Free Click for PET: Rapid 1,3-Dipolar Cycloadditions with a Fluorine-18 Cyclooctyne

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Copper-free click--a promising tool for pre-targeted PET imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

From mechanism to mouse: a tale of two bioorthogonal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Biomedical applications of tetrazine cycloadditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin αvβ₃ targeted PET tracer based on a cyclic RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Cross-coupling reactions as valuable tool for the preparation of PET radiotracers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Formation of ArF from LPdAr(F): catalytic conversion of aryl triflates to aryl fluorides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Molecular Imaging and Contrast Agent Database (MICAD): Evolution and Progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Immuno-PET of cancer: a revival of antibody imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Radiomics: extracting more information from medical images using advanced feature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0590-Y

Impact of animal handling on the results of 18F-FDG PET studies in mice.

21 January 2018

1 reference

12 December 2020

Synthesis and evaluation of nucleoside radiotracers for imaging proliferation

1 reference

12 December 2020

5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis

1 reference

12 December 2020

Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?

1 reference

12 December 2020

Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10.

1 reference

12 December 2020

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

1 reference

12 December 2020

In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

1 reference

12 December 2020

Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients

1 reference

12 December 2020

Copper-free click chemistry with the short-lived positron emitter fluorine-18

1 reference

12 December 2020

Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging

1 reference

12 December 2020

Synthesis of [18F]-labeled (6-fluorohexyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography

1 reference

12 December 2020

Rationale of 5-(125)I-iodo-4'-thio-2'-deoxyuridine as a potential iodinated proliferation marker.

1 reference

12 December 2020

10.1007/S11307-012-0590-Y

Identifiers

DOI

1 reference

27 August 2017

1 reference